Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02113046
Other study ID # R09131
Secondary ID
Status Terminated
Phase N/A
First received March 26, 2014
Last updated April 9, 2014
Start date October 2009
Est. completion date July 2013

Study information

Verified date April 2014
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority Finland:Tampere University Hospital Ethical committee
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate whether finnish binding pancreatico-jejunal anastomosis is feasible and prevents the risk for post operative pancreatic fistula after distal pancreeatectomy.


Recruitment information / eligibility

Status Terminated
Enrollment 47
Est. completion date July 2013
Est. primary completion date July 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- patiens which the distal pancreatic resektions

- the type of resections that is techically possible with finnish binding panceatico-jejunal anastomosis

Exclusion Criteria:

- if the pancreas is not suitable for this kind of anastomosis

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
pancreatico-jejunal anastomosis

traditional anastomosis


Locations

Country Name City State
Finland Tampere University hospital Tampere

Sponsors (1)

Lead Sponsor Collaborator
Tampere University Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative pancreatic fistula rata 30 days Yes
Secondary Number of patients with resection margin on the left side of portal vein as a measure of feasibility. 30 days Yes